RBR-8zzwfn尚未招募1 期
Expansion of virus specific lymphocytes for cell therapy in immunosuppressed patients submitted to bone marrow transplant - : Cell therapy for CMV infection in transplanted patients
Sociedade Beneficente Israelita Brasileira - Hospital Israelita Albert Einstein0 个研究点开始时间: 2019年3月20日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
入选标准
- •Patients of both sexes. Patients who have undergone allogeneic bone marrow transplantation. Patients who have cytomegalovirus infection or reactivation without clinical improvement or CMV copy decline after at least 2 weeks of treatment with standard anti-viral therapy.
排除标准
- •Patients who have received ATG, Campath or other immunosuppressive monoclonal antibody in less than 28 days. Patients who have received infusion of donor lymphocytes in less than 28 days. Patients with other uncontrolled infections than cytomegalovirus. Patients with Grade II to IV active graft versus host disease (GVHD). Patients receiving corticosteroid therapy with equivalent or higher doses of prednisone 0.5mg/kg.
研究者
相似试验
招募中
1 期
Expansion of Virus-Specific Lymphocytes for Cell TherapyCMV ViremiaCMVNCT06011486Hospital Israelita Albert Einstein10
招募中
1 期
Third-party derived multiple virus specific T-cell therapy for virus infectioJPRN-jRCTa030230316Morio Tomohiro21
招募中
1 期
Adoptive T-cell Therapy for Resistant Viral Infections After Allogeneic HSCT ( VS-TC )Patients who have received an allogeneic haematopoietic stem cell transplant and who have developed post-transplant viral reactivation (CMV, Adenovirus, EBV) resistant to pharmacological therapiesMedDRA version: 20.1Level: PTClassification code 10056559Term: Graft infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2021-005150-28-ITIRCCS ISTITUTO GIANNINA GASLINI10
已完成
不适用
Latent Viral Infection of Lymphoid Cells in Idiopathic Nephrotic SyndromeNEPHROSIS, LIPOIDNCT00577525Assistance Publique - Hôpitaux de Paris401
招募中
2 期
Third Party Viral Specific T-cells (VSTs)Viral InfectionViral ReactivationInfection in an Immunocompromised HostNCT02532452Children's Hospital Medical Center, Cincinnati1,000